e-learning
resources
Glasgow 2004
Wednesday 08.09.2004
Molecular biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tissue inhibitor of metalloproteinase 3 inhibits growth of lung cancer tumours in nude mice
K. M. Finan, G. Hodge, A. M. Reynolds, A. H. Baker, P. N. Reynolds (Adelaide, Australia; Glasgow, United Kingdom)
Source:
Annual Congress 2004 - Molecular biology
Session:
Molecular biology
Session type:
Oral Presentation
Number:
4324
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. M. Finan, G. Hodge, A. M. Reynolds, A. H. Baker, P. N. Reynolds (Adelaide, Australia; Glasgow, United Kingdom). Tissue inhibitor of metalloproteinase 3 inhibits growth of lung cancer tumours in nude mice. Eur Respir J 2004; 24: Suppl. 48, 4324
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Inhibition of tumor growth and metastatic lung tumors in mice by adenovirus-mediated interferon-β gene therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 199s
Year: 2003
Benzamidine-type urokinase inhibitors reduce primary tumor growth in a Lewis lung carcinoma model
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005
Adenovirus-mediated interferon-beta gene therapy inhibits tumor growth and inhibits metastatic lung tumors in mice
Source: Eur Respir J 2002; 20: Suppl. 38, 186s
Year: 2002
Interleukin-17 enhances the net angiogenic potential and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis
Source: Eur Respir J 2004; 24: Suppl. 48, 79s
Year: 2004
Adipocyte-derived exosomes promote lung cancer metastasis byincreasing MMP9 activity via transferring MMP3 to lung cancer cells
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
Proteinase inhibition regulates the anti-tumor activity of PAI-1 towards lung and prostate cancer cells
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
D104N poluymorphism in endostatin, an angiogenesis inhibitor, in lung cancer susceptibility
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010
ADAMTS-1 metalloproteinase promotes tumor development through the induction of a stromal reaction in vivo
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
Adenylate cyclase-associated protein 1 is associated with metastasis of non-small cell lung cancer especially in brain metastasis patients and promotes the lung cancer cell proliferation and migration in vitro as well as its growth and metastasis in vivo by the signaling pathways of limk1-cofilin
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015
The effect of matrix metalloproteinase-9 and vascular endothelial growth factor expression on survival of non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 324s
Year: 2005
Association of tissue inhibitor of metalloproteinases 2 and 3 polymorphisms with non-small cell Lung cancer
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Simultaneous inhibition of CTGF and Autotaxin reduces lung fibrosis and improves lung function in mice
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021
Tiotropium inhibits growth of squamous cell lung carcinoma (SCC) cell lines
in vitro
and also inhibits SCC growth
in vivo
in nude mice by inhalation
Source: Annual Congress 2010 - New insights in the pathology of lung cancer
Year: 2010
Connective tissue growth factor (CTGF) induces lung fibrosis in otherwise fibrosis-resistant Balb/c mouse in a bleomycin model
Source: Eur Respir J 2004; 24: Suppl. 48, 104s
Year: 2004
ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumour metastasis
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
Why is allograft formation in SCID mice slow in lung adenocarcinoma cell line with EGFR activating mutation?
Source: Annual Congress 2010 - New insights in the pathology of lung cancer
Year: 2010
Over-expression of aquaporin-5 increases migration and metastatic potential of lung cancer cells
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009
The effects of hypoxia on the expression of MMP-2, MMP-9 in human lung adenocarcinoma A549 cells
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014
Bevacizumab (Avastin®) aerosol therapy (AT) inhibits primary and metastatic tumor growth in a murine model with human non-small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Effects of ASCL1 expression on tumorigenesis and immune cell infiltration in a syngenic mouse model of lung adenocarcinoma
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept